Jeff Cehelsky
Impact in
- Epidemiology top 10%
- Respiratory viral infections research
- Pneumonia and Respiratory Infections
- Infectious Diseases top 10%
- Viral gastroenteritis research and epidemiology
Papers in
-
- Amyloidosis: Diagnosis, Treatment, Outcomes 4
- Protein Degradation and Inhibitors 2
- RNA modifications and cancer 2
-
- Respiratory viral infections research 6
- Co-authors
- John P. DeVincenzo (6 shared papers)Akshay Vaishnaw (12 shared papers)Rene Alvarez (3 shared papers)Iva Toudjarska (2 shared papers)Lubomir V. Nechev (3 shared papers)Jens Harborth (1 shared paper)Sayda M. Elbashir (1 shared paper)Rachel Meyers (3 shared papers)
- Journals
- Journal of Clinical Oncology (2 papers)Neurology (2 papers)Journal of the Peripheral Nervous System (1 paper)Arteriosclerosis Thrombosis and Vascular Biology (1 paper)Nucleic Acid Therapeutics (1 paper)
- Partner nations
- United StatesGermanyAustralia
In The Last Decade
Jeff Cehelsky
15 papers receiving 622 citations
Peers
Comparison fields: 5 of 57
- Epidemiology 322
- Infectious Diseases 109
- Genetics 49
- Cancer Research 65
- Pulmonary and Respiratory Medicine 118
Countries citing papers authored by Jeff Cehelsky
This map shows the geographic impact of Jeff Cehelsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeff Cehelsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeff Cehelsky more than expected).
Fields of papers citing papers by Jeff Cehelsky
This network shows the impact of papers produced by Jeff Cehelsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeff Cehelsky. The network helps show where Jeff Cehelsky may publish in the future.
Co-authors
The 25 scholars most cited alongside Jeff Cehelsky, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 239 | |
| 2 | 2008 | 197 | |
| 3 | 2006 | 83 | |
| 4 | 2011 | 44 | |
| 5 | 2014 | 31 | |
| 6 | Results of a phase 2b multi-center trial of ALN-RSV01 in respiratory syncytial virus (RSV)-infected lung transplant patients | 2012 | 15 |
| 7 | 2012 | 7 | |
| 8 | 2010 | 7 | |
| 9 | 2015 | 5 | |
| 10 | 2010 | 4 | |
| 11 | 2016 | 3 | |
| 12 | Interim results from phase ii trial of aln-ttr02, a novel RNAi therapeutic for the treatment of familial amyloidotic polyneuropathy | 2013 | 2 |
| 13 | ALN-TTR, an RNAI therapeutic for the treatment of transthyretin amyloidosis | 2011 | 1 |
| 14 | 2015 | 1 | |
| 15 | 2008 | 1 |
About Jeff Cehelsky
Jeff Cehelsky is a scholar working on Molecular Biology, Epidemiology, Surgery, Infectious Diseases and Genetics, having authored 15 papers that have together received 640 indexed citations. Recurring topics across this work include Respiratory viral infections research (6 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (4 papers), Virus-based gene therapy research (2 papers), Cancer Genomics and Diagnostics (2 papers), Protein Degradation and Inhibitors (2 papers), Cancer Research and Treatments (2 papers), Transplantation: Methods and Outcomes (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Epidemiology (322 citations), Infectious Diseases (109 citations), Genetics (49 citations), Cancer Research (65 citations) and Pulmonary and Respiratory Medicine (118 citations). Jeff Cehelsky has collaborated with scholars based in United States, Germany and Australia. Frequent co-authors include John P. DeVincenzo, Akshay Vaishnaw, Rene Alvarez, Iva Toudjarska, Lubomir V. Nechev, Jens Harborth, Sayda M. Elbashir, Rachel Meyers, Alex Mann and Preston H. Dorsett. Their work appears in journals such as Journal of Clinical Oncology, Neurology, Journal of the Peripheral Nervous System, Arteriosclerosis Thrombosis and Vascular Biology and Nucleic Acid Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.